We are live on ! Find out more
XPH icon

State Street SPDR S&P Pharmaceuticals ETF
XPH

71 hedge funds and large institutions have $98.4M invested in State Street SPDR S&P Pharmaceuticals ETF in 2024 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 18 increasing their positions, 24 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 8

0% more funds holding

Funds holding: 71 → 71 (0)

3.58% less ownership

Funds ownership: 56.38% → 52.8% (-3.6%)

7% less capital invested

Capital invested by funds: $105M → $98.4M (-$7.06M)

25% less repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 24

38% less call options, than puts

Call options by funds: $834K | Put options by funds: $1.35M

Holders
71
Holders Change
–
Holders Change %
0%
% of All Funds
1.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
18
Reduced
24
Closed
8
Calls
$834K
Puts
$1.35M
Net Calls
-$519K
Net Calls Change
+$150K

Top Buyers

Rank Fund Capital Flow
1
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$4.32M
2
Citigroup
Citigroup
New York
+$2.14M
3
Citadel Advisors
Citadel Advisors
Florida
+$1.02M
4
GS
GTS Securities
New York
+$784K
5
Goldman Sachs
Goldman Sachs
New York
+$623K

Top Sellers

Rank Fund Capital Flow
1
EH
Equitable Holdings
New York
-$10.4M
2
KWM
Kingsview Wealth Management
Oregon
-$5.92M
3
CI
Clal Insurance
Israel
-$4.28M
4
Jane Street
Jane Street
New York
-$2.24M
5
Bank of America
Bank of America
North Carolina
-$1.23M
Name Holding Trade Value Shares
Change 		Change in
Stake
RJA
26
Raymond James & Associates
Florida
$337K +$16K +373 +5%
Commonwealth Equity Services
27
Commonwealth Equity Services
Massachusetts
$330K +$3.38K +79 +1%
Osaic Holdings
28
Osaic Holdings
Arizona
$320K -$10.5K -245 -3%
FFA
29
Fragasso Financial Advisors
Pennsylvania
$293K -$17.5K -409 -6%
D.E. Shaw & Co
30
D.E. Shaw & Co
New York
$290K +$280K +6,538 New
CNC
31
Citizens & Northern Corp
Pennsylvania
$282K +$272K +6,347 New
AA
32
AlphaMark Advisors
Kentucky
$276K +$14.9K +348 +6%
Cambridge Investment Research Advisors
33
Cambridge Investment Research Advisors
Iowa
$260K -$7.24K -169 -3%
Jane Street
34
Jane Street
New York
$259K -$2.24M -52,269 -90%
Truist Financial
35
Truist Financial
North Carolina
$243K +$235K +5,484 New
CAPTRUST Financial Advisors
36
CAPTRUST Financial Advisors
North Carolina
$236K -$428 -10 -0.2%
Baird Financial Group
37
Baird Financial Group
Wisconsin
$234K – – –
RWP
38
RWA Wealth Partners
Massachusetts
$220K +$212K +4,956 New
TSS
39
Two Sigma Securities
New York
$219K +$212K +4,943 New
VIM
40
Vista Investment Management
Pennsylvania
$216K +$208K +4,866 New
Janney Montgomery Scott
41
Janney Montgomery Scott
Pennsylvania
$213K -$39.8K -930 -16%
JP Morgan Chase
42
JP Morgan Chase
New York
$197K +$50.6K +1,182 +36%
Fidelity Investments
43
Fidelity Investments
Massachusetts
$167K – – –
CIBC Private Wealth Group
44
CIBC Private Wealth Group
Georgia
$123K – – –
National Bank of Canada
45
National Bank of Canada
Quebec, Canada
$122K +$6.42K +150 +6%
NS
46
NBC Securities
Alabama
$103K +$43 +1 +0%
Bank of Montreal
47
Bank of Montreal
Ontario, Canada
$101K -$97.5K -2,276 -50%
NP
48
NorthRock Partners
Minnesota
$67K +$300 +7 +0.5%
AWM
49
Angeles Wealth Management
California
$44.4K – – –
WT
50
Whittier Trust
California
$39.5K – – –
1
2
3 4

XPH Hedge Fund Activity: Q3 2024 in Review

71 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in State Street SPDR S&P Pharmaceuticals ETF (XPH) for Q3 2024, worth a combined $98.4M — down 6.7% from $105M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new XPH positions and 8 closed out — a net gain of 1 holder — while 18 added to existing stakes and 24 trimmed.

The largest buyer was BNP Paribas Financial Markets, adding an estimated $4.32M. The largest seller was Equitable Holdings, exiting entirely with an estimated $10.4M sold.

  • 71 institutional investors held State Street SPDR S&P Pharmaceuticals ETF (XPH) as of Q3 2024, unchanged from Q2 2024.
  • Funds reported $98.4M of State Street SPDR S&P Pharmaceuticals ETF stock for Q3 2024, down 6.7% quarter-over-quarter.
  • 9 funds opened new State Street SPDR S&P Pharmaceuticals ETF positions in Q3 2024 and 8 closed out, a net change of +1 holder.
  • The largest State Street SPDR S&P Pharmaceuticals ETF buyer in Q3 2024 was BNP Paribas Financial Markets, an estimated $4.32M added.
  • The largest State Street SPDR S&P Pharmaceuticals ETF seller in Q3 2024 was Equitable Holdings, an estimated $10.4M sold.

Based on aggregated 13F filings for Q3 2024.